Immune system study in desmoid fibromatosis patients
Part of Cancer clinical trials.
This study looks at the immune system of people with desmoid fibromatosis. It aims to understand how the immune system behaves in patients who are either watching their tumor (active surveillance) or getting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sporadic desmoid-type fibromatosis
- Your disease is measurable (can be seen on scans)
- You are either under active surveillance (no active treatment) or receiving systemic treatment (medications)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This study looks at immune cells in your blood to find patterns that might show how well a treatment called anti-PD1 immunotherapy works for melanoma. Your participation could help doctors better understand who benefits from this therapy.
This study follows people with desmoid-type fibromatosis using scans and health information to see how the tumor behaves. It may help patients and doctors decide when “watch and wait” is the right approach and when treatment is needed.
This study tests a new medication for adults with desmoid tumors (rare, slow-growing tumors that form in connective tissue). You may qualify if your tumor has grown recently, causes pain, or has come back after previous treatment.
This trial tests a treatment called arterial embolization for desmoid tumors (non-cancerous growths) that are causing symptoms and growing. The goal is to see if blocking the blood supply to the tumor can shrink it or stop it from growing.
This study follows patients with desmoid tumors who are having a procedure called ablation, which uses heat or cold to destroy the tumor. The study asks patients about their symptoms and quality of life after the procedure to see how well it works.
Hear when a new Desmoid-Type Fibromatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.